Brain Cancer Vaccine's Immune Response Key to Outcomes (HealthDay)

[feedbot]

Brain Cancer Vaccine's Immune Response Key  to Outcomes (HealthDay)

HealthDay - TUESDAY, July 15 (HealthDay News) -- An in-trial dendritic cell vaccine
that fights malignant brain tumors called glioblastoma multiforme (GBM)
may help boost a patient's immunity response and improve the outcome, a
new report says.

http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/braincancervaccinesimmuneresponsekeytooutcomes.html